An interventional study of Electrical Activation Mapping Guided Cardiac resynchronization therapy in Heart Failure, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-16.
Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Heart Failure by Chinese University of Hong Kong — 7 open to participants now, 7 under way, 1 of them phase 3. Heart Failure · Chinese University of Hong Kong.
Among the 15 studies in Heart Failure by Chinese University of Hong Kong, this one is the only one that started in 2019, is one of 7 with no phase, and was the 9th registered.
6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.
Browse Heart Failure studies →7 of the 15 studies in Heart Failure by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:
Chinese University of Hong Kong · Sites in Hong Kong
Ages 19+
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18+ · Healthy volunteers
Chinese University of Hong Kong · Sites in Hong Kong
Ages 19+
Chinese University of Hong Kong · Sites in Hong Kong
Ages 19+
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18+
By country, each count listing its studies:
Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 1 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 27 is below the median of 76 across 4,053 interventional studies indexed under Heart Failure.
Median enrollment 93 across the 8 interventional studies, 242 across the 7 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chinese University of Hong Kong is the lead sponsor of 1,458 studies on the registry; 478 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
1 of the studies in Heart Failure by Chinese University of Hong Kong that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05556031Chinese University of Hong KongAmbulatory Heart Failure Service Model Study | 2027-10 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Heart Failure by Chinese University of Hong Kong, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background Cardiac Resynchronization Therapy (CRT) is proven to improve survival and heart function of patient with certain electrical conduction abnormality and heart failure. However, in patient with certain electrical conduction abnormality, being nonresponder is observed in up to 40% in patient receiving CRT. Conventionally the surgical approach of CRT is to implant one pacing lead in the right heart and one in the left heart to resynchronize the contraction and the pacing lead in the left heart is usually placed in the posterior or lateral portion of the left heart. However, this single approach may not be optimal, especially for those patients with conduction abnormality known to have no response to CRT. Purpose of the clinical investigation The purpose of the Activation Pattern and Acute Hemodynamics of His and Left Bundle Pacing is to study the acute effect on the heart function and conduction abnormality of His and left bundle pacing in conventional CRT candidate. During CRT implantation, Hisbundle lead and Left bundle pacing lead will be placed and the acute effect on heart function will be studied by a wire placed in the left ventricle of the heart and the activation pattern will be studied by a noninvasive global mapping system. The pacing approach that optimally corrects conduction abnormality and improvement on the heart function acutely will be determined
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cardiac resynchronization therapy given according to Electrical Activation Mapping result
Device: Electrical Activation Mapping Guided Cardiac resynchronization therapy
To study the feasibility to optimize configuration of CRT delivery for acute correction of electrical dyssynchrony using a noninvasive mapping of global electrical activation
Improvement in myocardiac activation
Correction of activation abnormality as evaluated by global noninvasive mapping system (ECGi) seen as an increase in acute dp/dt \> 5% from baseline with left bundle pacing comparing to biventricular pacing.
Time frame: 6 months
Procedure duration
Procedure duration of the optimal CRT delivery method as determined by the best improvement in electrical desynchrony indices.
Time frame: during procedure
Implantation success rate
Implantation success rate of the optimal CRT delivery method as determined by the best improvement in electrical desynchrony indices.
Time frame: during procedure
Cine images and chest X ray
Cine images (PA, LAO 300, RAO 300) and Chest X ray (PA view) obtained during course of study for assessment of disease
Time frame: 6 months
Echocardiogram parameters: strain imaging
Echocardiogram parameters: strain imaging at baseline, 3 months and 6 months
Time frame: 6 months
Echocardiogram parameters: left ventricular systolic and diastolic volume
Echocardiogram parameters: left ventricular systolic and diastolic volume at baseline, 3 months and 6 months
Time frame: 6 months
Echocardiogram parameters: left ventricular ejection fraction
Echocardiogram parameters: left ventricular ejection fraction at baseline, 3 months and 6 months
Time frame: 6 months
Echocardiogram parameters: degree of mitral regurgitation
Echocardiogram parameters at baseline, 3 months and 6 months
Time frame: 6 months
Change in New York Heart Association class
Comparison of NYHA class at baseline, 3 months and 6 months to assess changes in quality of life of subject.
Time frame: 6 months
Device parameter: defibrillation threshold
Electrical parameters including defibrillation threshold at implant and 6 months follow-up.
Time frame: 6 months
post-operative complication rate
Peri-operative and 6 months follow-up complications rate: 1. Thromboembolic event 2. Dislodgement and migration of pacing leads 3. Phrenic nerve stimulation 4. Others
Time frame: 6 months
Device parameter: defibrillation sensitivity
Electrical parameters including defibrillation sensitivity at implant and 6 months follow-up.
Time frame: 6 months
Device parameter: lead impedance
Electrical parameters including lead impedance of pacing leads at addition of new lead and 6 months follow-up.
Time frame: 6 months
Change in 6 minute hall walk test result
Comparison of 6 minute hall walk test result at baseline, 3 months and 6 months to assess changes in quality of life of subject.
Time frame: 6 months
Change in HF Patient Global Assessment Questionnaire outcome
Comparison of HF Patient Global Assessment Questionnaire outcome at baseline, 3 months and 6 months to assess changes in quality of life of subject.
Time frame: 6 months
Ran from Jul 2019 to primary completion in Dec 2023, 53 months.
Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's 53 months is above that.
Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong →